BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Doxycycline
,
rs6983267
,
SLC12A1
,
nitric oxide metabolic process
,
Allergy to pollen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
oteracil
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treat…
Low-dose apatinib and tegafur-gimeracil-oteracil as palliative treatment in recurrent cervical cance…
Rapidly progressive glomerulonephritis caused by tegafur/gimeracil/oteracil resulted in diabetes nep…
Efficacy of paclitaxel and S-1 combined with apatinib in the conversion therapy for unresectable adv…
Comparative Outcomes of First-Line Chemotherapy for Metastatic Pancreatic Cancer Among the Regimens …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CCRT Followed by Tegafur, Gimeracil and Oteracil Potassium in Cervical Cancer
A Study of Apatinib and Tegafur Gimeracil Oteracil in Locally Advanced Squamous Cell Carcinoma of th…
A Study of Apatinib Plus Tegafur Gimeracil Oteracil in Recurrent/Metastatic Head and Neck Cancers
Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
Adjuvant Chemotherapy in Combination With Camrelizumab for Stage III Gastric Cancer (FOCUS-02)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ